Question

Respiratory disorder due to excessive pollution resulting in collapse and alveolar breakdown is
A) Emphysema
B) Hydrothorax
C) Cyanosis
D) All of the above

Answer 1

Respiratory disorders are types of disorders that affect the lungs and other parts of the respiratory system. The affected person may develop breathing difficulties.

Complete answer:
Respiratory disorders or lung diseases are disorders that affect the organs and tissues that make gas exchange difficult in air breathing in animals. It may be caused by some infections, by smoking, or breathing in polluted air. Some of the respiratory tract diseases include the following asthma, chronic obstructive pulmonary diseases (COPD), chronic bronchitis, emphysema, cystic fibrosis, etc.

Emphysema: It is a lung condition which causes shortness of breath. In people with emphysema the air sacs in the lungs get damaged. These symptoms of emphysema include frequent coughing or wheezing, shortness of breath, tightness in the chest etc. The cause of emphysema is generally long term exposure to irritants that damage the lungs.
Hydrothorax: It is a type of pleural effusion in which transudates accumulate in the pleural cavity. This condition is most likely to occur after congestive heart failure. It is generally a condition where a non inflammatory collection of serous fluid in the pleural cavities.
Cyanosis: it is the bluish or purplish discoloration of the skin or the mucous membrane. It occurs because the tissues near the skin surface have less amount of oxygen saturation. The term cyanosis is literally known as the blue disease or blue condition. The causes include intracranial hemorrhage, drug overdose, pneumonia, bronchitis, pulmonary hypertension, etc.
From the above information we can conclude that emphysema is the disorder that occurred due to excessive pollution resulting in collapse and alveolar breakdown.

Hence the correct answer for the above question is option (A) emphysema

Note: There are different types of respiratory disorders which include asthma, chronic obstructive pulmonary diseases (COPD), chronic bronchitis, emphysema, cystic fibrosis.